DELIVER THERAPEUTICS
DELIVER Therapeutics provides modern research tools and approaches that are rapidly implicating new types of disease targets beyond the scope that have been โdrug-ableโ by traditional drug discovery techniques. Deliver is pushing the limits by discovering next-generation therapeutics through the application of innovative chemical screening methodologies to enable the modulation of highly validated yet less traditional targets involved in the development and progression of cancer and aging.
DELIVER THERAPEUTICS
Social Links:
Industry:
Biopharma Health Care Hospital
Founded:
2020-01-01
Address:
Surfside, California, United States
Country:
United States
Website Url:
http://www.delivertherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Current Employees Featured
Founder
Official Site Inspections
http://www.delivertherapeutics.com
- Host name: 162.2.196.104.bc.googleusercontent.com
- IP address: 104.196.2.162
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "DELIVER Therapeutics"
About Us โ DELiver Therapeutics
He is also the founder and CEO of Ponce Therapeutics, Inc. (https://poncetherapeutics.com), which reunites the team that founded Bellicum Pharmaceuticals and that is using advanced technologies to develop novel โฆSee details»
DELiver Therapeutics โ Deliver Therapeutics โ Using โฆ
Jul 20, 2024 Regulating the Senescence-Associated Secretory Phenotype (SASP) Cellular senescence is characterized by irreversible cell cycle arrest and a proinflammatory senescence-associated secretory phenotype (SASP), โฆSee details»
DELIVER Therapeutics Company Profile 2024: Valuation, Funding ...
DELIVER Therapeutics General Information Description. Developer of drug therapeutics designed to address cancer, aging disorders, and problems in clinical medicine. The company's โฆSee details»
DELIVER Therapeutics - Crunchbase Company Profile & Funding
DELIVER Therapeutics provides modern research tools and approaches that are rapidly implicating new types of disease targets beyond the scope that have been โdrug-ableโ by โฆSee details»
DELiver Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore DELiver Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Neoplasms, Endocrinology and Metabolic ...See details»
DELIVER Therapeutics, Inc. Overview | SignalHire Company Profile
Organization Website: delivertherapeutics.com : DELIVER Therapeutics... industries Biotech: Headquarters Location: 2710 Reed Rd, Houston, Texas, 77051 US 2710 Reed Rd, Houston, โฆSee details»
Contact Us โ DELiver Therapeutics
R&D Facility Location. 2710 Reed Road, Suite 160 Houston, TX 77051 Attn: David Spencer, Ph.D. [email protected]See details»
DELIVER Therapeutics, Inc. | LinkedIn
DELIVER Therapeutics, Inc. | 148 followers on LinkedIn. Applying high throughput screening technologies to deliver novel therapeutics | Applying high throughput DNA encoded library โฆSee details»
Rapha Capital BioVentures Fund I Launches DELIVER Therapeutics โฆ
Dec 14, 2021 DELIVER is headquartered in Miami, Florida with research facilities located in Houston, TX. For more information about DELIVER Therapeutics, Inc., email โฆSee details»
DELIVER Therapeutics, Inc. Information - RocketReach
Delivertherapeutics.com; View Similar People. Related Companies CEMEX USA. 1,230 $271.4m Stage Inc. 3 $1b Tekmetric. 167 $5m Amplify Energy Corp. 108 $357.7m TMC Library. 38 โฆSee details»
DELIVER Therapeutics - Overview, News & Similar companies
View DELIVER Therapeutics (www.delivertherapeutics.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
DELiver Therapeutics - VentureRadar
Website: https://delivertherapeutics.com/ Develops next-generation therapeutics using innovative chemical screening methodologies to address challenges in cancer and ...See details»
DELIVER Therapeutics, Inc. - Company Profile & Staff Directory
Applying novel, high throughput screening technologies to deliver therapeutics that address the most difficult problems in clinical medicineSee details»
DELiver Therapeutics - Company Profile - Tracxn
Oct 18, 2024 DELiver Therapeutics ranks 1,661st among 2362 active competitors. 847 of its competitors are funded while 544 have exited. Overall, DELiver Therapeutics and its โฆSee details»
DELiver Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Jul 6, 2023 Explore DELiver Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news.See details»
Pipeline โ DELiver Therapeutics
Our early pipeline is focused on identifying novel small molecule candidates that are both first-in-class and best-in-class.See details»
David Spencer, Ph.D โ DELiver Therapeutics
David is an internationally recognized leader in synthetic molecular biology with over 25 years of experience, focusing on biomedical applications with emphasis on regulation of vaccines and โฆSee details»
Rapha Capital BioVentures Fund I Launches DELIVER Therapeutics โฆ
Dec 14, 2021 Rapha Capital Management, LLC is providing this website for informational purposes only. Nothing on this website is intended to constitute, or should be deemed to be, โฆSee details»
250 Drug Delivery Companies Worldwide - Biotech Careers
Kindeva is a pharmaceutical contract development and manufacturing organization (CDMO). Kytogenics. Business Area(s): Drug Delivery; Description: Drug Delivery, Medical Products. โฆSee details»
Technology โ DELiver Therapeutics
IL-1, IL-6, IL-8, TNF-ฮฑ, TGF-ฮฒ, and various matrix metalloproteinases (MMP3, 12) make up the key components of the SASP. The sustained inflammatory microenvironment created by the โฆSee details»